NC

Nexthera Capital Portfolio holdings

AUM $120M
1-Year Return 20.18%
This Quarter Return
+13.95%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
10 Year Return
AUM
$227M
AUM Growth
+$41.1M
Cap. Flow
+$29.3M
Cap. Flow %
12.91%
Top 10 Hldgs %
56.37%
Holding
55
New
14
Increased
8
Reduced
9
Closed
18
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INDP icon
26
Indaptus Therapeutics
INDP
$3.65M
$2.47M 0.64%
+123
New +$2.47M
MDGL icon
27
Madrigal Pharmaceuticals
MDGL
$9.65B
$1.28M 0.33%
+28,536
New +$1.28M
STDY
28
DELISTED
SteadyMed Ltd
STDY
$867K 0.22%
258,918
-101,708
-28% -$341K
ZSAN
29
DELISTED
Zosano Pharma Corporation
ZSAN
$309K 0.08%
537
-61
-10% -$35.1K
VTGN icon
30
VistaGen Therapeutics
VTGN
$109M
$221K 0.06%
4,604
AVEO
31
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$190K 0.05%
+5,200
New +$190K
CBAY
32
DELISTED
Cymabay Therapeutics
CBAY
$121K 0.03%
+15,000
New +$121K
TSRO
33
DELISTED
TESARO, Inc.
TSRO
-9,300
Closed -$1.3M
KITE
34
DELISTED
Kite Pharma, Inc.
KITE
-100,000
Closed -$10.4M
CELG
35
DELISTED
Celgene Corp
CELG
-99,110
Closed -$12.9M
ABEO icon
36
Abeona Therapeutics
ABEO
$353M
-14,160
Closed -$2.27M
AZN icon
37
AstraZeneca
AZN
$253B
0
KMDA icon
38
Kamada
KMDA
$411M
-300,781
Closed -$1.81M
NGNE icon
39
Neurogene
NGNE
$285M
-4,535
Closed -$1.28M
OVID icon
40
Ovid Therapeutics
OVID
$87.5M
-30,543
Closed -$320K
PFE icon
41
Pfizer
PFE
$141B
-368,932
Closed -$11.8M
TEVA icon
42
Teva Pharmaceuticals
TEVA
$21.7B
0
VNDA icon
43
Vanda Pharmaceuticals
VNDA
$272M
-462,200
Closed -$7.53M
XBI icon
44
SPDR S&P Biotech ETF
XBI
$5.39B
0
RNTX
45
Rein Therapeutics, Inc. Common Stock
RNTX
$31M
-5,705
Closed -$1.27M
TVRD
46
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
0
KDNY
47
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-31,000
Closed -$1.77M
SIOX
48
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
0
OBSV
49
DELISTED
ObsEva SA Ordinary Shares
OBSV
-35,000
Closed -$299K
SRRA
50
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-10,000
Closed -$468K